Biomarker Testing and the Ovarian Cancer Diagnostics and...

σε πρόσθεσε στο Health

2026-10-29 10:31:52 - Μετάφραση -

Biomarker Testing and the Ovarian Cancer Diagnostics and Therapeutics Market

Biomarker testing has become central to ovarian cancer care. Measuring CA-125 and other biomarkers supports diagnosis, monitoring, and treatment decisions, while genetic testing for BRCA mutations identifies patients who may benefit from PARP inhibitors. Biomarker testing is a fast-growing segment of the ovarian cancer diagnostics and therapeutics market, and it is reshaping clinical practice....

0 Σχόλια 0 Μοιράστηκε 98 Views 0 Προεπισκόπηση